The latest price target for PainReform (NASDAQ:PRFX) was reported by Maxim Group on October 24, 2024. The analyst firm set a price target for $0.00 expecting PRFX to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for PainReform (NASDAQ:PRFX) was provided by Maxim Group, and PainReform downgraded their hold rating.

There is no last upgrade for PainReform

The last downgrade for PainReform Ltd happened on October 24, 2024 when Maxim Group changed their price target from N/A to N/A for PainReform Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PainReform, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PainReform was filed on October 24, 2024 so you should expect the next rating to be made available sometime around October 24, 2025.

While ratings are subjective and will change, the latest PainReform (PRFX) rating was a downgraded with a price target of $0.00 to $0.00. The current price PainReform (PRFX) is trading at is $1.33, which is out of the analyst’s predicted range.